Table 5. Association results of rs765250 with essential hypertension and blood pressure variation per cohort and meta-analyses.
Study | Population | Na | Case/Control | EH | SBP | DBP | |||
OR (CI)b | p-valuec | Effect (se)b | p-valuec | Effect (se)b | p-valuec | ||||
Original Study | BRIGHT | 3400 | 1700/1700 | 1.3(1.0,1.7) | 0.015 | 0.04(0.01) | 0.0005 | 0.032(0.011) | 0.002 |
Replication studies | HYPEST | 1246 | 596/650 | 1.2(0.8,1.8) | 0.2 | 0.02(0.01) | 0.03 | 0.01(0.01) | 0.1 |
LOLIPOP | 943 | 485/458 | 1.3(0.8,2.1) | 0.1 | 0.03(0.02) | 0.09 | 0.03(0.02) | 0.06 | |
Whitehall I | 1002 | 466/536 | 1.2(0.8,1.9) | 0.3 | 0.02(0.03) | 0.2 | 0.01(0.03) | 0.3 | |
ELSA | 5422 | 2323/2745 | 1.2(1.0,1.5) | 0.03 | 0.02(0.01) | 0.008 | 0.02(0.01) | 0.005 | |
Whitehall II | 4867 | 1247/3620 | 0.8(0.6,1.0) | 0.1 | 0.004(0.01) | 0.3 | −0.001(0.007) | 0.4 | |
Olivetti | 971 | 165/447 | 0.8(0.5,1.3) | 0.5 | −0.004(0.01) | 0.4 | −0.01(0.01) | 0.2 | |
Meta-Analysis | Replication | 14451 | 5282/8456 | 1.1(0.9,1.2) | 0.3 | 0.1(0.004) | 0.007 | 0.007(0.004) | 0.06 |
Test for heterogeneity | I2 = 30.5%,p = 0.22 | I2 = 0%,p = 0.42 | I2 = 40.5%,p = 0.14 | ||||||
Meta-Analysis d | Combined | 17851 | 6982/10156 | 1.1(1.0,1.3) | 0.04 | 0.01(0.004) | 0.0002 | 0.01(0.006) | 0.06 |
Test for heterogeneity | I2 = 35.7%,p = 0.16 | I2 = 39.1%,p = 0.13 | I2 = 52.9%,p = 0.047 |
Effective number – maximum number of individuals available for analysis.
Odds ratio and confidence intervals for EH using 10 K bootstrap samples. For the replication cohorts and meta analyses 90% confidence intervals are reported as all analyses were performed with the prior hypothesis that carriers of rs765250 allele A (A/A+A/G vs G/G) would be at increased risk for EH compared to G/G homozygotes.
For the replication cohorts and meta analyses one-tailed p-values are reported.
For EH and SBP results were combined under a fixed effects model. DBP showed evidence for heterogeneity and was analysed using a random-effects model.